FDA Inspection 1337286 — Nizar J. Bahlis, M.D.
The FDA completed an inspection of Nizar J. Bahlis, M.D. on Sep 4, 2026 in Calgary. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 4, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Calgary (Canada)
Additional Details
Clinical Investigator (CI)